PT  - JOURNAL ARTICLE
AU  - Myroniuk, Tyler W.
AU  - Hermsen, Joan M.
AU  - Hamilton, Christal
AU  - David, Ifeolu
AU  - Teti, Michelle
AU  - Ranjit, Yerina S.
AU  - Woodrey, Shannen N.
AU  - Stilley, Julie A.W.
AU  - Teixeiro, Emma
AU  - Guan, Yue
AU  - Daniels, Mark
AU  - Schatz, Enid
TI  - The MU Study of Seropositivity and Risk for SARS-CoV-2 and COVID-19: Crucial Behavioral and Immunological Data from Midwestern College Students
AID  - 10.1101/2022.01.24.22269758
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.24.22269758
4099  - http://medrxiv.org/content/early/2022/01/25/2022.01.24.22269758.short
4100  - http://medrxiv.org/content/early/2022/01/25/2022.01.24.22269758.full
AB  - Objective We describe our Fall 2020 study of college students’ COVID-19 related behaviors, attitudes, and antibody test results.Participants The study included 1,446 randomly selected and self-enrolled undergraduate and graduate students from a midwestern university.Methods An online survey was distributed to a sample of students, between September and December 2020. A sub-group also participated in a SARS-CoV-2 antibody blood draw.Results Nearly half of students reported a prior COVID-19 test with 22% indicating a positive test, which represents an 11% positivity rate across all student participants. Of those who participated in antibody testing, 15.1% tested positive for SARS-CoV-2 antibodies. Seventy-seven percent of participants said they would get vaccinated. One-third of students reported moderate to severe generalized anxiety disorder and 13% reported moderate to severe depression.Conclusions This study informed campus decisions in Fall 2020. The importance of effective public health messaging on campus should continue in the future.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by University of Missouri CARES and Siemens Healthineers.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of the University of Missouri gave ethical approval for this work (protocol #2028427).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData produced in the present study are available upon reasonable request to the authors.